CAS: 1204707-71-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SRT3109 REF: IN-DA008TJPCAS: 1204707-71-0 | % | To inquire | Tue 26 Nov 24 |
 | SRT3109 REF: TM-T3047CAS: 1204707-71-0 | 99.65% - 99.92% | 41.00 €~1,188.00 € | Tue 03 Dec 24 |
 | AZD 5069 REF: 3D-FD41314CAS: 1204707-71-0 | Min. 95% | 314.00 €~874.00 € | Tue 10 Dec 24 |
Ref: IN-DA008TJP
| 50mg | 555.00 € | ||
| 100mg | 589.00 € |
Estimated delivery in United States, on Tuesday 26 Nov 2024
SRT3109
CAS:1204707-71-0
SRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions.
Formula:
C18H23F2N5O4S2
Purity:
99.65% - 99.92%
Color and Shape:
Solid
Molecular weight:
475.53
Ref: TM-T3047
| 2mg | 41.00 € | ||
| 5mg | 60.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 170.00 € | ||
| 50mg | 299.00 € | ||
| 1mL*10mM (DMSO) | 64.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
AZD 5069
CAS:1204707-71-0
CXCR2 antagonist
Formula:
C18H23F2N5O4S2
Purity:
Min. 95%
Color and Shape:
White To Off-White Solid
Molecular weight:
475.11595
Ref: 3D-FD41314
| 10mg | 314.00 € | ||
| 50mg | 874.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
